Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation
Advanced Materials · 2026
DOI: 10.1002/adma.202516597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Kai Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Department of Traditional Chinese Medicine of Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Educat…. Hauptthemen laut MEDLINE: Cellular Senescence, Immunologic Surveillance, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cellular senescence can recruit immune cells for tumor therapy through the senescence‐associated secretory phenotype (SASP). However, its therapeutic efficacy is limited by immune tolerance and the immunosuppressive tumor microenvironment (TME). Reprogramming tumor‐specific senescence through coordinated modulation of P16 INK4a and PD‐L1 enhances tumor immunogenicity and alleviates immunosuppression. To achieve this, a target‐enhanced gene delivery nanoparticle is engineered using the urokinase plasminogen activator receptor (uPAR) as a senescence‐specific targeting ligand, combined with a telomerase reverse transcriptase (TERT) promoter and a nuclear localization signal‐microtubule‐associated sequence (NLS‐MTAS) peptide. This system efficiently induces tumor‐specific senescence through cell‐cycle arrest and promotes the chemotactic recruitment of cytotoxic immune cells. In vivo, the nanoparticle induces a robust anti‐tumor response without causing systemic toxicity and significantly enhances the therapeutic efficacy of αCTLA‐4 immune checkpoint blockade in subcutaneous, lung metastasis, postoperative recurrence, and spontaneous tumor models. This study emphasizes the therapeutic potential of reprogramming tumor‐specific senescence to improve targeted gene delivery and immunotherapy outcomes, offering a viable approach for the treatment of immunologically “cold” tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Department of Traditional Chinese Medicine of Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, 430072, P.R. China.
ORCID-Profile: Xian-Zheng Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, K., Yan, Y., Dong, B. T., Pan, S. S., & Zhang, X. Z. (2026). Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation. Advanced Materials. https://doi.org/10.1002/adma.202516597
Vancouver
Zhao K, Yan Y, Dong BT, Pan SS, Zhang XZ. Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation. Advanced Materials. 2026. doi:10.1002/adma.202516597
BibTeX
@article{Zhao2026,
author = {Zhao, Kai and Yan, Yu and Dong, Bao-Ting and Pan, Shan-Shan and Zhang, Xian-Zheng},
title = {Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202516597}
}
EUVIMED